MOXIE SELECT EXCLUSIVE: Well-established company comprising three fully licensed and contracted pharmacies located in NY & NJ, each with multiple state licenses. This operation includes an anchor sterile and non-sterile, hazardous and non-hazardous 503A compounding pharmacy, with a significant GLP1 segment accredited by ACHC and PCAB, ensuring top-tier quality and compliance. Boasting over 15 years of successful business, the group of pharmacies collectively average 1,000+ prescriptions daily and generate over $35 million in gross revenue annually, with net profits exceeding $7 million. Each location has a full team in place, and the experienced licensed pharmacist owners are committed to a smooth transition, willing to remain for as long as needed. This is a prime opportunity for buyers seeking a robust pharmacy operation with a strong reputation and consistent performance.

This business is ideal for a group seeking to vertically integrate their GLP1 portfolio with their own sterile compounding facility, with a team experienced and capable of handling high-value prescriptions and quick turnaround for DTC models.